Safety monitoring of bivalent, quadrivalent, and 9-valent human papillomavirus vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study

Safety data on human papillomavirus (HPV) vaccination in the Japanese population remain limited owing to the lack of healthcare databases available for vaccine safety assessment. In this study, we assessed the risk of adverse events of special interest (AESIs) following HPV vaccination among females...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Chieko Ishiguro, Hiroya Morita, Wataru Mimura, Shinya Tsuzuki, Junko Hirashima-Terada, Yoshinori Takeuchi, Futoshi Oda, Megumi Maeda, Haruhisa Fukuda
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Taylor & Francis Group 2026-12-01
Sarja:	Human Vaccines & Immunotherapeutics
Aiheet:	HPV vaccines safety routinely collected health data post-authorization phase pharmacovigilance
Linkit:	https://www.tandfonline.com/doi/10.1080/21645515.2026.2688606
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!